Corneal inlay

AcuFocus has announced that Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, Austria, presented data on the five-year postoperative performance of the KAMRA inlay at the recent 26th International Congress of German Ophthalmic Surgeons (DOC) meeting. According to Dr Grabner’s data, at five years following implantation, patients with the inlay continue to have great vision. He reported, on average in the inlay eye patients achieve J2 uncorrected near visual acuity and 20/25 for both uncorrected intermediate and distance visual acuities. Over this same timeframe the fellow, non-implanted eye, in this same cohort of patients lost lines of near, intermediate and distance visual acuity. “This data underscores that the KAMRA inlay is effective over the long-term, delivering a full range of vision and patient satisfaction,” noted Dr Grabner.
“The safety profile for a corneal procedure is much greater than for a lens-based procedure, making the inlay an ideal ‘first choice’ for presbyopic patients. Since the inlay is removable, should it require removal – a rare occurrence at <2 per cent commercially – the patients still have all options available for presbyopia correction.”
www.AcuFocus.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.